Abstract
The concept of tumor heterogeneity, (tumors composed of genetically polymorphic subpopulations), has been well recognized by cancer researchers for many years, (see Furth, 1959; Kim and Depowski, 1975), and by physicians whose patients have experienced a recurrence of cancers that had initially responded to certain anticancer drugs. Indeed, the recognition of phenotypic heterogeneity of tumors is the rational basis for the development of modern multiple-drug modalities in the treatment of advanced cancer patients, (see Skipper, 1983). Lately, interest on this topic seems to have been rekindled by the demonstration of various phenotypic traits in clones of cells isolated in vivo or in vitro from tumors of diverse origin, (Heppner, 1984). In addition to the difference in drug sensitivity, tumor heterogeneity includes variations in cellular structure and functional differentiation, growth pattern, hormone dependence, antigenic expression, metastatic potential, and stem cell karyotype. With the availability of more sensitive markers, coupled with the refinement of detection techniques, an even greater genetic diversity of tumor cells is likely to be discovered in the future. However, knowledge as to the mechanism by which neoplastic cells acquire such heritable characteristics during the oncogenic process, as well as to the evolution of each trait in the course of tumor progression, it still quite limited. A critical review of the natural history of various experimental mammary tumors developed in our laboratory, including a systematic tracing of their acquisition of new characteristics, may shed some light on the subject.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aamdal, S., Bormer, O., Jorgensen, O., Host, H., Eliassen, G., Kaalhus, O., and Pihl, A., 1984, Estrogen receptors and long-term prognosis in breast cancer, Cancer 53: 2525–2529.
Abercrombie, A., and Ambrose, E. J., 1962, The surface properties of cancer cells: A review, Cancer Res. 22: 525–548.
Anderson, D. E., 1973, A high risk group for breast cancer, Cancer Bull. 2: 23–25.
Arafah, B. M., Finegan, H. M., Roe, J., Manni, A., and Pearson, O. H., 1982, Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors, Endocrinology 111: 584–588.
Armstrong, B., and Doll, R., 1975, Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices, Int. J. Cancer 15: 617–631.
Armstrong, B., Stevens, N., and Doll, R., 1974, Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women, Lancet 2: 672–675.
Balner, H., and Dersjant, H., 1966, Neonatal thymectomy and tumor induction with methylcholanthrene in mice, J. Natl. Cancer Inst. 36: 513–521.
Beatson, G. T., 1896, On the treatment of inoperable cases of carcinoma of the mamma: Suggestion for a new method of treatment with illustrative cases, Lancet 2: 104–162.
Bentvelzen, P., and Hilgers, J., 1980, Murine mammary tumor virus, in: Viral Oncology (G. Klein, ed.), Raven Press, New York, pp. 311–355.
Bern, H. A., and Nandi, S., 1961, Recent studies of the hormonal influence in mammary tumorigenesis, Prog. Exp. Tumor Res. 2: 90–144.
Bernacki, R., and Kim, U., 1977, Concomitant elevation in sialyltransferase activity and sialic acid content in rats with metastasizing mammary tumors, Science 195: 577–580.
Bibbo, M., Haenzel, W. M., Wied, G. L., Hubby, M., and Herbst, A. L., 1978, A twenty-five year follow-up study of women exposed to diethylstilbestrol during pregnancy, N. Engl. J. Med. 298: 763–767.
Bittner, J. J., 1940, Further studies on active milk influence in breast cancer production in mice, Proc. Soc. Exp. Biol. Med. 45: 805–810.
Bittner, J. J., 1942, Possible relationship of the estrogenic hormones, genetic susceptibility, and milk influence in the production of mammary cancer in mice, Cancer Res. 2: 710–721.
Bittner, J. J., 1947, Mammary tumor milk agent, Ann. N. Y. Acad. Sci. 49: 69–73.
Bittner, J. J., 1962, Biological assay and serial passage of the mouse mammary tumors from mothers and their inbred progeny, in: A Ciba Foundation Symposium on Tumour Viruses of Murine Origin (G. E. W. Wolstenholme and M. O’Connor, eds.), Little, Brown, Boston, pp. 56–71.
Bjelke, E., 1975, Dietary Vitamin A and human lung cancer, Int. J. Cancer 15: 561–565.
Bland, K. I., Fuchs, A., and Wittliff, J. L., 1981, Menopausal status as a factor in the distribution of estrogen and progestin receptors in breast cancer, Surg. Forum 32: 410–412.
Bollag, W., 1972, Prophylaxis of chronically induced benign and malignant epithelial tumors by vitamin A acid, (retinoic acid), Eur. J. Cancer 8: 689–693.
Boot, L. M., Mühlbock, O., Ropcke, G., and Van Ebbenhorts Tangbergen, W., 1962, Further investigations on induction of mammary cancer in mice by isografts of hypophyseal tissue, Cancer Res. 22: 713–727.
Bostocchi, M., Nuti, M., and Squartini, F., 1977, Quantitative comparison on milk-release C3H and RIII mammary tumor viruses in infected BALB/ch hosts, Tumori 63: 535–542.
Bowers, C. Y., Friesen, H. G., Hwang, P., Guyda, H. J., and Folkers, K., 1971, Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide, Biochem. Biophys. Res. Commun. 45: 1033–1041.
Brock, D. J. H., and Sutcliffe, R. G., 1972, Alfa-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida, Lancet 2: 197.
Bronn, D. G., Webster, D. J. T., and Minton, J. P., 1978, Estrogen receptor levels in hormonally progressive mammary tumors, Surg. Forum 29: 174–176.
Bruni, J. E., and Montemurro, D. G., 1971, Effect of hypothalamic lesions on the genesis of spontaneous mammary tumors in the mouse, Cancer Res. 31: 854–863.
Bulbrook, R. D., Hayward, J. L., and Spencer, C. C., 1971, Relation between urinary androgen and corticoid excretion and subsequent breast cancer, Lancet 2: 395–398.
Burnet, F. M., 1970, Immunological Surveillance, Pergamon Press, Elmsford, N.Y. Burrows, H., and Horning, E. S., 1952, Oestrogens and Neoplasia, Blackwell, Oxford.
Cancer Research Supplement, 1983, Workshop conference on nutrition in cancer causation and prevention, Cancer Res. Suppl. 43: 2385s - 2519s.
Cardiff, R. D., and Young, J. T., 1980, Mouse mammary tumor biology: A new synthesis, in: Viruses in Naturally Occurring Cancers, ( M. Essex, G. Todaro, and H. zur Hausen, eds.), Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 1105–1114.
Carroll, K. K., 1973, Experimental evidence of dietary factors and hormone dependent cancers, Cancer Res. 33: 3374–3383.
Carroll, K. K., and Khor, H. T., 1970, Effects of dietary fat and dose level on 7,12-dimethyl- benz(a)anthracene on mammary tumor incidence in rats, Cancer Res. 30: 2260–2264.
Cave, W. T., Jr., Dunn, J. T., and MacLeod, R. M., 1979, Effects of iodine deficiency and high-fat diet on N-nitrosomethylurea-induced mammary cancer in rats, Cancer Res. 39: 729–734.
Chan, P.-C., Didato, F., and Cohen, L. A., 1975, High dietary fat, elevation of rat serum prolactin, and mammary tumors, Proc. Soc. Exp. Biol. Med. 149: 132–135.
Chatterjee, S. K., and Kim, U., 1977, Galactosyltransferase activity in metastasizing and non-metastasizing rat mammary carcinomas and its possible relationship with tumor cell surface antigen shedding, J. Natl. Cancer Inst. 58: 273–280.
Chatterjee, S. K., and Kim, U., 1978, Fucosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas, J. Natl. Cancer inst. 61: 151–162.
Chopra, I. J., Hershman, J. M., and Hornabrook, R. W., 1976, Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea, J. Clin. Endocrinol. Metab. 40: 326–333.
Cohen, J. C., Shank, P. R., Morris, V. L., Cardiff, R., and Varmus, H. E., 1979, Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse, Cell 16: 333–345.
Cohen, S. M., Wittenberg, J. F., and Bryan, G. T., 1976, Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolylj-formamide, Cancer Res. 36: 2334–2339.
Cooper, G. M., 1982, Cellular transforming genes, Science 217: 801–806.
Costlow, M. E., Buschow, R. A., Richert, N. J., and McGuire, W. L., 1975, Prolactin and estrogen binding in transplantable hormone-dependent and autonomous mammary carcinoma, Cancer Res. 35: 970–974.
Cowan, L. D., Gordis, L., Tonascia, J. A., and Jones, G. S., 1981, Breast cancer incidence in women with a history of progesterone deficiency, Am. J. Epidemiol. 114: 209–217.
Cox, F. E. G., 1984, How parasites evade the immune response, Immunol. Today 1984: 29–33.
Cronkite, E. P., Shellabarger, C. J., Bond, V. P., and Lippincott, S. W., 1957, Studies of the mechanism of induction of radiation-induced tumors of the breast in the rat, Radiat. Res. 7: 311.
Cutts, J. H., 1969, Unusual response to androgen of estrogen dependent mammary tumors, J. Natl. Cancer Inst. 42: 485–488.
Cutts, J. H., and Noble, R. L., 1964, Estrogen-induced mammary tumors in the rat. I. Induction and behavior of tumors, Cancer Res. 24: 1116–1123.
Dao, T. L., Bock, F. G., and Greiner, M. J., 1960, Mammary carcinogenesis by 3-methylcholanthrene. II. Inhibitory effect of pregnancy and lactation on tumor induction, J. Natl. Cancer Inst. 25: 991–1003.
De Baetselier, P., Katzav, S., Gorelik, E., Feldman, M., and Segal, S., 1980, Differential expression of H-2 gene products in tumour cells is associated with their metastatogenic properties, Nature 288: 179–181.
De la Monte, S. M., Hutchins, G. M., and Moore, G. W., 1984, Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma, Am. J. Med. 76: 11–17.
Drasar, B. S., and Irving, D., 1975, Environmental factors and cancers of the colon and breast, Br. J. Cancer 27: 167–172.
Dunnington, D. J., Kim, U., Hughes, C. M., Monaghan, P., and Rudland, P. S., 1984, Lack of production of myoepithelial variants by cloned epithelial cell lines derived from the TMT081 metastasizing rat mammary tumor, Cancer Res. 44: 5338–5346.
Edgington, T. S., and Nakamura, R. M., 1982, Tumor associated and tumor specific markers of human mammary cancer, in: Serono Symposium No. 46, Markers for Diagnosis and Monitoring Human Cancer, ( M. I. Colnaghi, G. L. Buraggi, and M. Ghione, eds.), Academic Press, New York, pp. 51–74.
Erickson, K. L., McNeill, C. J., Gershwin, M. E., and Ossmann, J. B., 1980, Influence of dietary fat concentration and saturation on immune ontogeny in mice, J. Nutr. 110: 1555–1572.
Eskin, B. A., 1970, Iodine metabolism and breast cancer, Trans. N. Y. Acad. Sci. 32: 911–947.
Faulkin, L. J., 1966, Hyperplastic lesions of mouse mammary glands after treatment with 3-methylcholanthrene, J. Natl. Cancer Inst. 36: 289–298.
Fidler, I. J., 1973, Selection of successive lines of metastasis, Nature New Biol. 242: 148–149.
Fisher, E. R., Redmond, C. K., Liu, H., Rockette, H., and Fisher, B., 1980, Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer, Cancer 45: 349–353.
Fisher, E. R., Redmond, C., Fisher, B., and participating NSABP investigators, 1983, Pathologic findings from the National Surpical Adjuvant Breast Project. VIII. Relationship of chemotherapeutic responsiveness to tumor differentiation, Cancer 51: 181–191.
Fishman, A. P., 1982, Endothelium: A distributed organ of diverse capacity, Ann. N.Y. Acad. Sci. 401: 1–8.
Fishman, J., Fukushima, D. K., O’Conner, J., and Lynch, H. T., 1979, Low urinary estrogen glucuronides in women at risk for familial breast cancer, Science 204: 1089–1091.
Foulds, L., 1949, Mammary tumours in hybrid mice: Growth and progression of spontaneous tumours, Br. J. Cancer 3: 345–375.
Furth, J., 1953, Conditioned and autonomous neoplasms. A review, Cancer Res. 13: 477–492.
Furth, J., 1959, A meeting of ways in cancer research: Thoughts on the evolution and nature of neoplasms, Cancer Res. 19: 241–258.
Furth, J., 1973, The role of prolactin in mammary carcinogenesis, in: Human Prolactin, ( J. L. Pasteels and C. Robyn, eds.), Exerpta Medica, Amsterdam, pp. 232–248.
Furth, J., and Clifton, K. H., 1966, Experimental pituitary tumors, in: The Pituitary Gland, ( G. W. Harris and B. T. Donovan, eds.), Butterworths, London, pp. 460–497.
Furth, J., and Furth, O., 1936, Neoplastic diseases produced by general irradiation with X-rays. I. Incidence and type of neoplasms, Am. J. Cancer 28: 54–65.
Gallager, S., 1984, Pathologic types of breast cancer: Their prognoses, Cancer 53: 623–629.
Ganther, H. E., Hafeman, D. G., Lawrence, R. A., Serfass, R. E., and Hoekstra, W. G., 1976, Selenium and glutathione peroxidase in health and disease—A review, in: Trace Elements in Human Health and Diseases, ( A. S. Presa, ed.), Academic Press, New York, pp. 165–234.
Gardner, W. U., 1957, Hormones and carcinogenesis, Proc. Can. Cancer Res. Conf. 2: 207–241.
Ghosh, S. K., Grossberg, S., Kim, U., and Pressman, D., 1979, A tumor-associated organ-specific antigen characteristic of spontaneously metastatic rat mammary carcinoma, J. Natl. Cancer Inst. 62: 1229–1233.
Ghosh, S. K., Roholt, O. A., and Kim, U., 1983, Antigenic characteristics of metastasizing and nonmetastasizing mammary adenocarcinoma of rat, in: Non-HLA Antigens in Health, Aging and Malignancy, ( E. Cohen, J. Fitzpatrick, and G. P. Murphy, eds.), Liss, New York, pp. 227–233.
Gorski, J., Toft, D., Shyamala, G., Smith, D., and Notides, A., 1968, Hormone receptor studies on the interaction of estrogen with the uterus, Recent Prog. Horm. Res. 24: 45–80.
Gray, G. E., Pike, M. C., and Henderson, B. E., 1979, Breast cancer incidence and mortality rates in different countries in relation to known risk factors and dietary practices, Br. J. Cancer 39: 1–9.
Gridley, D. S., Kettering, J. D., Garaza, C. D., Andres, M. L., Slater, J. M., and Nutter, R. L., 1982, Modification of herpes 2-transformed cell-induced tumors in mice fed different source of protein, fat, and carbohydrate, Cancer Lett. 17: 161–173.
Gridley, D. S., Kettering, J. D., Slater, J. M., and Nutter, R. L., 1983, Modification of spontaneous mammary tumors in mice fed different sources of protein, fat and carbohydrate, Cancer Lett. 19: 133–146.
Gruenstein, M., Meranze, D. R., and Acuff, M., 1968, The role of thyroid in hydrocarbon-induced mammary carcinogenesis in rats, Cancer Res. 28: 471–474.
Guffy, M. M., Rosenberger, J. A., Simon, I., and Burns, C. P., 1982, Effect of cellular fatty acid alteration on hyperthermic sensitivity in cultured L1210 murine leukemia cells, Cancer Res. 42: 3625–3630.
Guffy, M. M., North, J. A., and Burns, C. P., 1984, Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukemia cells, Cancer Res. 44: 1863–1866.
Guillemin, R., Yamazaki, E., Gard, D. A., Jutisz, M., and Sakiz, E., 1963, In vitro secretion of thyrotropin (TSH): Stimulation by a hypothalamic peptide (TRF), Endocrinology 73: 564–572.
Gullino, P. M., Pettigrew, H. M., and Grantham, F. H., 1975, N-nitrosomethylurea as mammary gland carcinogen in rats, J. Natl. Cancer Inst. 54: 401–409.
Hanna, N., 1980, Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity, Int. J. Cancer 26: 675–680.
Harr, J. R., Exon, J. H., Weswig, P. H., and Whanger, P. D., 1973, Relationship of dietary selenium concentration, chemical cancer induction and tissue concentration of selenium in rats, Clin. Toxicol. 6: 287–293.
Haughton, G., and Whitmore, A. C., 1976, Genetics, the immune response and oncogenesis, Transplant. Rev. 28: 75–97.
Henderson, B. E., Powell, D., Rosario, I., Keys, C., Hanisch, R., Young, M., Casagrande, J., Gerkins, V., and Pike, M. C., 1974, An epidemiologic study of breast cancer, J. Natl. Cancer Inst. 53: 609–614.
Henderson, B. E., Gerkins, V., Rosario, I., Casagrande, J., and Pike, M. C., 1975, Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer, N. Engl. J. Med. 292: 790–795.
Heppner, G. H., 1984, Tumor heterogeneity, Cancer Res. 44: 2259–2265.
Herberman, R. B., and Ortaldo, J. R., 1981, Natural killer cells: Their role in defenses against disease, Science 214: 24–30.
Heuson, J. C., and Legros, N., 1970, Influence of insulin and of aloxan diabetes on growth of the rat mammary carcinoma in vivo, Eur. J. Cancer 6: 349–351.
Heuson, J. C., Legros, N., and Heimann, R., 1972, Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized and hypophysectomized rats, Cancer Res. 32: 233–238.
Hewitt, H. B., and Blake, E. R., 1975, Quantitative studies of translymphnodal passage of tumor cells naturally disseminated from a nonimmunogenic murine squamous carcinoma, Br. J. Cancer 31: 25–35.
Hewitt, H. B., Blake, E. R., and Walder, A. S., 1976, A critique of the evidence for active host defense against cancer, based on personal studies of 27 murine tumors of spontaneous origin, Br. J. Cancer 33: 241–259.
Hilf, R., Hissin, P. J., and Shafie, S. M., 1978, Regulatory interrelationships for insulin and estrogen action in mammary tumors, Cancer Res. 38: 4075–4085.
Hirayama, T., 1978, Epidemiology of breast cancer with special reference to the role of diet, Prey. Med. 7: 173–195.
Horwitz, K. B., and McGuire, W. L., 1975, Specific progesterone receptors in human breast cancer, Steroids 25: 497–505.
Howard, D. K., Schlom, J., and Fisher, P. B., 1983, Chemical carcinogen—mouse mammary tumor virus interactions in cell transformation, In Vitro 19: 58–66.
Huggins, C., and Fukunishi, R., 1963, Cancer in the rat after single exposure to irradiation or hydrocarbons. Age and strain factors. Hormone dependence of the mammary cancers, Radiat. Res. 20: 493–503.
Huggins, C., Briziarelli, G., and Suton, H., 1959, Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors, J. Exp. Med. 109: 25–42.
Huggins, C., Grand, L. C., and Brillantes, F., 1961, Mammary cancer induced by a single feeding of polynuclear hydrocarbon and its suppression, Nature 189: 204–207.
Huggins, C., Moon, R. C., and Morii, S., 1962, Extinction of experimental mammary cancer. I. Estradiol-17/3 and progesterone, Proc. Natl. Acad. Sci. USA 48: 379–386.
Hwang, P., Guyda, H., and Friesen, H., 1971, A radioimmunoassay for human prolactin, Proc. Natl. Acad. Sci. USA 68: 1902–1906.
Ichinose, R. R., and Nandi, S., 1966, Influence of hormones on lobulo-alveolar differentiation of mouse mammary gland in vitro, J. Endocrinol. 35: 331–340.
Ip, C., 1981, Factors influencing the anticarcinogenic efficacy of selenium on dimethyl- benz(a)anthracene-induced mammary tumorigenesis in rats, Cancer Res. 41: 2683–2686.
Ip, C., and Ip, M. M., 1981, Serum estrogen and estrogen responsiveness in 7,12-dimethylbenz(a)anthracene-induced mammary tumors as influenced by dietary fat, J. Natl. Cancer Inst. 66: 291–295.
Ip, C., and Sinha, D. K., 1981, Enhancement of mammary tumorigenesis by dietary selenium deficiency in rats with a high polyunsaturated fat intake, Cancer Res. 41: 31–34.
Ip, C., Yip, P., and Bernardis, L. L., 1980, The role of prolactin in the promotion of dimethyl- benz(a)anthracene-induced mammary tumors by dietary fat, Cancer Res. 40: 374–378.
Ip, M. M., Milholland, R. J., Kim, U., and Rosen, F., 1978, Characterization of androgen receptors in 7,12-dimethylbenz(a)anthracene-induced and transplantable rat mammary tumors, Cancer Res. 38: 2879–2885.
Ip, M., Milholland, R. J., Rosen, F., and Kim, U., 1979, Mammary cancer: Selective action of the estrogen receptor complex, Science 203: 361–363.
Itoh, K., and Maruchi, N., 1975, Breast cancer in patients with Hashimoto’s thyroiditis, Lancet 2: 1119–1121.
Jacobs, M. M., 1980, Effects of selenium on chemical carcinogenesis, Prey. Med. 9: 362–367.
Jacobs, D. M., and Byrd, W., 1975, Addult thymectomy results in loss of T-dependent mitogen response in mouse spleen cells, Nature 255: 153–155.
Jensen, E. V., Suzuku, T., Kawashima, T., Stumpf, W. E., Jungblut, P. W., and DeSombre, E. R., 1968, A two-step mechanism for the interaction of estradiol with rat uterus, Proc. Natl. Acad. Sci. USA 59: 632–639.
Jensen, E. V., Block, G. E., Smith, S., Keyser, K., and DeSombre, E. R., 1971, Estrogen receptors and breast cancer response to adrenalectomy, Natl. Cancer Inst. Monogr. 34: 55–79.
Jull, J. W., 1958, Hormonal mechanisms in mammary carcinogenesis, in: Endocrine Aspects of Breast Cancer, ( A. R. Currie and C. F. W. Illingworth, eds.), Livingstone, Edinburgh, pp. 305–317.
Kalpaktsoglou, P. K., Yunis, E. J., and Good, R. A., 1967, Early splenectomy and survival of inbred mice, Nature 215: 633–634.
Kapdi, C. C., and Wolf, J. N., 1976, Breast cancer—Relationship to thyroid supplements for hypothyroidism, J. Am. Med. Assoc. 23: 1124–1127.
Katz, L., Steinitz, R., and Sela, T., 1981, Epidemiological review of breast cancer in Israel, Isr. J. Med. Sci. 17: 810–815.
Kellen, J. A., 1972, Effect of hypothyroidism on induction of mammary tumors in rats by 7,12dimethylbenz(a)anthracene, J. Natl. Cancer Inst. 48: 1901–1904.
Keydar, I., Selzer, G., Chaitchik, S., Horeuveni, M., Karby, S., and Hizi, A., 1982, A viral antigen as a marker for the prognosis of human breast cancer, Eur. J. Cancer Clin. Oncol. 18: 1321–1328.
Kiang, D. T., and Kennedy, B. J., 1977, Factors affecting estrogen receptors in breast cancer, Cancer 40: 1571–1576.
Kim, U., 1970, Metastasizing mammary carcinomas in rats: Induction and study of their immunogenicity, Science 167: 72–74.
Kim, U., 1977, Pathogenesis of spontaneously metastasizing mammary carcinomas in rats, Gann Monogr. 20: 73–81.
Kim, U., 1983, On the characteristics of tumor cells and host responses associated with metastatic potential, in: 13th International Cancer Congress, Part C, Biology of Cancer, ( E. Mihich and E. Mirand, eds.), Liss, New York, pp. 45–50.
Kim, U., and Depowski, M., 1975, Progression from hormone dependence to autonomy in mammary tumors as an in vitro manifestation of sequential clonal selection, Cancer Res. 35: 2068–2077.
Kim, U., and Furth, J., 1960a, Relation of mammary tumors to mammotropes. I. Induction of mammary tumors in rats, Proc. Soc. Exp. Biol. Med. 103: 640–642.
Kim, U., and Furth, J., 1960b, Relation of mammary tumors to mammotropes. II. Hormone responsiveness of 3-methylcholanthrene induced mammary carcinomas, Proc. Soc. Exp. Biol. Med. 103: 643–645.
Kim, U., and Furth, J., 1961, Relation of mammary tumors to mammotropes. IV. Development of highly hormone-dependent mammary tumors. Proc. Soc. Exp. Biol. Med. 105: 490–492.
Kim, U., and Furth, J., 1976, The role of prolactin in carcinogenesis, Vitam. Horm., (N.Y.), 34: 107–136.
Kim, U., Furth, J., and Yannopoulos, K., 1963, Observations on hormonal control of mammary cancer. I. Estrogen and mammotropes, J. Natl. Cancer Inst. 31; 233–259.
Kim, U., Baumler, A., Carruthers, C., and Bielat, K., 1975, Immunological escape mechanism in spontaneously metastasizing mammary tumors, Proc. Natl. Acad. Sci. LISA 72: 1012–1016.
Klug, H. L., Moxon, A. L., Petersen, D. F., and Painter, E. P., 1953, Inhibition of rat liver succinic dehydrogenase by selenium compounds, J. Pharmacol. Exp. Ther. 108: 437–441.
Kollmorgen, G. M., Sansing, W. A., Lehman, A. A., Fischer, G., Longley, R. E., Alexander, S. S., Jr., King, M. M., and McCoy, P. B., 1979, Inhibition of lymphocyte function in rats fed high-fat diets, Cancer Res. 39: 3458–3462.
Kubai, L., and Auerbach, R., 1968, Neonatal splenectomy: Absence of runting in mice, Nature 217: 460.
Kwa, H. G., DeJong-Bekker, M., Engelsman, E., and Cleton, F. J., 1974, Plasma-prolactin in human breast cancer, Lancet 1: 433–434.
Lacassagne, A., and Duplan, J. F., 1959, Le mécanisme de la cancérisation de la mamelle chez la Souris, considéré d’apre les résultats d’expériences au moyen de la réserpine, C. R. Acad. Sci. 249: 810–812.
Lewko, W. M., and McConnell, W. P., 1982, Biphasic influence of selenium on cell growth and the synthesis of collagen in cultured mammary tumor cells, Fed. Proc. 41: 623.
Lo, L. W., Koropatnick, J., and Stitch, H. F., 1978, The mutagenicity and cytotoxicity of selenite, “activated” selenite and selenate for normal and DNA repair-deficient human fibroblasts, Mutat. Res. 49: 305–312.
Loeb, L., and Kirtz, M. M., 1939, The effects of transplants of anterior lobes of the hypophysis on the growth of the mammary gland and on the development of mammary gland carcinoma in various strains of mice, Am. J. Cancer 36: 56–82.
Lorber, J., Stewart, C. R., and Ward, A. M., 1973, Alfa-fetoprotein in antenatal diagnosis of anencephaly and spina bifida, Lancet 1: 1187.
Lynch, H. T., Albano, W. A., Danes, B. S., Layton, M. A., Kimberling, W. J., Cheng, S. C., Costello, K. A., Mulcahy, G. M., Wagner, C. A., and Tindall, S. L., 1984, Genetic predisposition to breast cancer, Cancer 53: 612–622.
Lyons, W. R., Li, C. H., and Johnson, R. E., 1958, The hormonal control of mammary growth and lactation, Recent Prog. Horm. Res. 14: 219–248.
McKeehan, W. L., Hamilton, W. G., and Ham, R. G., 1976, Selenium is an essential trace element for growth of W-38 diploid human fibroblasts, Proc. Natl. Acad. Sci. USA 73: 2023–2027.
MacMahon, B., Cole, P., and Brown, J., 1973, Etiology of human breast cancer: A review, J. Natl. Cancer Inst. 50: 21–42.
Maiorana, A., and Gullino, P. M., 1980, Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice, J. Natl. Cancer Inst. 64: 655–663.
Medina, D., and Shepherd, F., 1980, Selenium-mediated inhibition of mammary tumorigenesis, Cancer Lett. 8: 241–245.
Medina, D., and Shepherd, F., 1981, Selenium-mediated inhibition of 7,12-dimethylbenz(a)anthracene-induced mouse mammary tumorigenesis, Carcinogenesis 2: 451–455.
Medina, D., De Orne, K. B., and Young, L., 1970, Tumor producing capabilities of hyperplastic alveolar nodules in virgin and hormone-stimulated BALB/c C3H and C3Hf mice, J. Natl. Cancer Inst. 44: 167–174.
Mehta, R. G., McCormick, D. L., Cerny, W., and Moon, R. C., 1982, Correlation between retinoid inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis and levels of retinoic acid binding proteins, Carcinogenesis 3: 89–91.
Mettlin, C., Graham, S., Priore, R., Marshall, J., and Swanson, M., 1981, Diet and cancer of the esophagus, Nutr. Cancer 2: 143–147.
Miller, J. F. A. P., Grant, G. A., and Roe, F. J. C., 1963, Effect of thymectomy on the induction of skin tumours by 3,4-benzpyrene, Nature 199: 920–922.
Mittra, I., and Haywood, J. L., 1977, The hypothalamic—pituitary—thyroid axis in breast cancer, Lancet 1: 885–889.
Moody, J. K., and Reed, N. D., 1968, Neonatal splenectomy and survival of mice, Nature 218: 1056–1057.
Moon, R. C., 1962, Influence of graded thyroxine levels on mammary gland, Am. J. Physiol. 203: 942–946.
Moon, R. C., and Mehta, R. G., 1982, Retinoid binding in normal and neoplastic mammary tissue, in: Hormones and Cancer, ( W. W. Leavit, ed.), Plenum Press, New York, pp. 231–249.
Moon, R. C., Grubbs, C. J., and Sporn, M. B., 1976, Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis by retinyl acetate, Cancer Res. 36: 2626–2630.
Moon, R. C., Grubbs, C. J., Sporn, M. B., and Goodman, D. G., 1977, Retinyl acetate inhibits mammary carcinogenesis induced by N-methyl-N-nitrosourea, Nature 267: 620–621.
Moon, R. C., McCormick, D. L., and Mehta, R. G., 1983, Inhibition of carcinogenesis by retinoid, Cancer Res., (Suppl.), 43: 2469–2475.
Moore, D. H., Charney, J., and Pullinger, B. D., 1970, Mouse mammary tumor virus infectivity as a function of age at inoculation, breeding, and total lapsed time, J. Natl. Cancer Inst. 45: 561–565.
Mori, S., 1922, The changes in the para-ocular glands which follow the administration of diets low in fat-soluble A; with notes of the effects of the same diets on the salivary glands and the mucosa of the larynx and trachea, Johns Hopkins Hosp. Bull. 33: 357–359.
Mühlbock, O., and Boot, L. M., 1959, Induction of mammary cancer in mice without the mammary tumor agent by isograft of hypophyses, Cancer Res. 19: 402–412.
Nagataki, S., Shizume, K., and Nakao, K., 1967, Thyroid function in chronic excess iodine ingestion: Comparison of thyroidal absolute iodine uptake and degradation of thyroxine in euthyroid Japanese subjects, J. Clin. Endocrinol. Metab. 27: 638–647.
Nandi, S. J., 1958, Endocrine control of mammary gland development in the C3H/He Crgl mouse, J. Natl. Cancer Inst. 21: 1039–1055.
Nandi, S., and Bern, H. A., 1960, Relation between mammary-gland responses to lactogenic hormone combinations and tumor susceptibility in various strains of mice, J. Natl. Cancer Inst. 24: 907–931.
Neri, A., and Nicolson, G. L., 1981, Phenotypic drift of metastatic and cell-surface properties of mammary adenocarcinoma cell clones during growth in vitro, Int. J. Cancer 28: 731–738.
Nishizuka, Y., Nakakuki, K., and Usui, M., 1965, Enhancing effect of thymectomy on hepatotumorigenesis in Swiss mice following neonatal injection of 20-methylcholanthrene, Nature 205: 1236–1238.
Noble, R. L., and Collip, J. B., 1941, Regression of estrogen-induced mammary tumors in female rats following removing of the stimulus, Can. Med. Assoc. J. 44: 1–5.
Nusse, R., and Varmus, H. E., 1982, Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome, Cell 31: 99–109.
Ossowski, L., and Reich, E., 1980, Experimental model for quantitative study of metastasis, Cancer Res. 40: 2300–2309.
Parish, C. R., O’Neill, H. C., and Higgins, T. J., 1981, Glycosyltransferases and T-cell recognition, Immunol. Today 2: 98–102.
Park, B. H., Fike, R. M., and Kim, U., 1982, Increased electrophoretic mobility of rat mammary tumor cells: A positive correlation with metastatic potential, IRCS Med. Sci. 10: 96–97.
Parsons, M., Nelson, R. G., and Agabian, N., 1984, Antigenic variation in African trypanosomes: DNA rearrangements program immune evasion, Immunol. Today 5: 43–50.
Peters, G., Brookes, S., Smith, R., and Dickson, C., 1983, Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors, Cell 33: 369–377.
Pingitore, R., and Squartini, F., 1982, Relationship between morphology and viral etiology in mammary tumors of BALB/cf C3H and BALB/cf RIII mice, Tumori 68: 199–203.
Prehn, R. T., and Main, J. M., 1957, Immunity to methylcholanthrene-induced sarcomas, J. Natl. Cancer Inst. 18: 769–778.
Rao, B. R., and Meyer, J. S., 1977, Estrogen and progestin receptors in normal and cancer tissue, in: Progesterone Receptors in Normal and Neoplastic Tissues, ( W. L. McGuire, J. P. Raynaud, and E. E. Baulieu, eds.), Raven Press, New York, pp. 155–169.
Rao, G. A., and Abraham, S., 1975, Enhanced growth rate of transplanted mammmary adeno- carcinomas induced in C3H mice by dietary linoleate, J. Natl. Cancer Inst. 54: 401–414.
Rhomberg, W., 1975, Metastasierendes Mammakarzinom and diabetes mellitus—Eine prog- nostisch günstige krankheitskombination, Dtsch. Med. Wochenschr. 100: 2422–2427.
Ringold, G. M., Dobson, D. E., Grove, J. R., Hall, C. V., Lee, F., and Vannice, J. L., 1983, Glucocorticoid regulation of gene expression: Mouse mammary tumor virus as a model system, Recent Prog. Horm. Res. 39: 387–424.
Rivera, E. M., 1966, Strain differences in mouse mammary tissue sensitivity to prolactin and somatotrophin in organ culture, Nature 209: 1151–1152.
Roder, J. C., and Haliotis, T., 1980, Do NK cells play a role in anti-tumor surveillance? Immunol. Today 1: 96–100.
Rogers, A. E., Herndon, B. J., and Newberne, P. M., 1973, Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high and low levels of vitamin A, Cancer Res. 33: 1003–1009.
Ross, R. K., Paganini-Hill, A., Gerkins, V. R., Mack, T. M., Pfeffer, R., Arthur, M., and Henderson, B. E., 1980, A case-control study of menopausal estrogen therapy and breast cancer, J. Am. Med. Assoc. 243: 1635–1639.
Rous, P., and Beard, J. W., 1935, The progression to carcinoma of virus-induced rabbit papilloma (Shope), J. Exp. Med. 62: 523–548.
Rous, P., and Kidd, J. G., 1941, Conditional neoplasms and subthreshold neoplastic states: A study of tar tumors of rabbits, J. Exp. Med. 73: 365–389.
Rudland, P. S., Bennett, D. C., and Warburton, M. J., 1979, Hormonal control of growth and differentiation of cultured rat mammary gland epithelial cells, in: Hormones and Cell Culture, Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., pp. 677–699.
Schally, A. V., and Bowers, C. Y., 1963, The nature of thyrotropin-releasing hormone (TRH), Proc. 6th Midwest. Conf. Thyroid Endocrinol. pp. 25–63.
Schirmacher, V., 1980, Shift in tumor cell phenotypes induced by signals from the microenvironment: Relevance for the immunobiology of cancer metastasis, Immunobiology 157: 89–98.
Severi, L., Biancifiori, C., Olivi, M., and Squartini, F., 1958, On hormone dependence in the transmission of mammary tumour agent from males, in: Endocrine Aspects of Breast Cancer, ( A. R. Currie and C. F. W. Illingworth, eds.), Livingston, Edinburgh, pp. 283–290.
Shamberger, G. N., White, D. A., and Schneider, C. J., 1978, Selenium and cancer: Effects of selenium and of the diet on the genesis of spontaneous mammary tumors in virgin inbred female C3H/St. mice, Bioinorg. Chem. 8: 387–396.
Shellabarger, C. J., Bond, V. P., and Cronkite, E. P., 1960, Studies on radiation-induced mammary gland neoplasia in the rat. IV. The response of females to a single dose of sublethal total-body gamma radiation as studied until first appearance of breast neoplasia to death of the animals, Radiat. Res. 13: 242–249.
Silverstone, H., and Tannenbaum, A., 1950, The effect of the proportion of dietary fat on the rate of formation of mammary carcinoma in mice, Cancer Res. 10: 448–453.
Singh, D. V., De Ome, K. B., and Bern, H. A., 1970, Strain differences in response of the mouse mammary gland to hormones in vitro, J. Natl. Cancer Inst. 45: 657–675.
Sinha, Y. N., Selby, F. W., and Vanderlaan, W. P., 1974, The natural history of prolactin and GH secretion in mice with high and low incidence of mammary tumors, Endocrinology 94: 757–764.
Skipper, H. E., 1983, Stepwise progress in the treatment of disseminated cancers, Cancer 51: 1773–1776.
Smithline, F., Sherman, L., and Kolodny, H. D., 1975, Prolactin and breast carcinoma, N. Engl. J. Med. 292: 784–792.
Spiegelman, S., 1974, Molecular evidence for viral agents in human cancer and its chemotherapeutic consequences, Cancer Chemother. Rep. 58: 595–613.
Spiegelman, S., Mesa-Tejada, R., Ohno, T., Ramanarayanan, M., Nayak, R., Bausch, J., and Fenoglio, C., 1980, The presence and clinical implications of a virus-related protein in human breast cancer, Cold Spring Harbor Conf. Cell Prolif. 7: 1149–1167.
Sporn, M. B., Squire, R. A., Brown, C. C., Smith, J. M., Wenk, M. L., and Springer, S., 1977, β-cis-retinoic acid: Inhibition of bladder carcinogenesis in the rat, Science 195: 487–489.
Squartini, F., and Bostocchi, M., 1977, Bioreactivity of C3H and RIII mammary tumor viruses in virgin female BALB/cf mice: Brief communication, J. Natl. Cancer Inst. 58: 1845–1847.
Stackpole, C. W., 1981, Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma, Nature 289: 798–800.
Stutman, O., 1982, Natural and induced immunity to mouse mammary tumors and the mammary tumor virus (MuMTV), in: Springer Seminars in Immunopathology, Springer-Verlag, Berlin, pp. 333–372.
Talwalker, P. K., and Meites, J., 1961, Mammary lobulo-alveolar growth induced by anterior pituitary hormones in adreno-ovariectomized and adreno-ovariectomized-hypophysectomized rats, Proc. Soc. Exp. Biol. Med. 107: 880–883.
Tashjian, A. H., Jr., Barosky, N. J., and Jensen, D. K., 1971, Thyrotropin-releasing hormone: Direct evidence for stimulation of prolactin production by pituitary cells in culture, Biochem. Biophys. Res. Commun. 43: 516–523.
Thomas, D. B., 1980, Epidemiologic and related studies of breast cancer etiology, in: Reviews in Cancer Epidemiology, Volume 1, ( A. M. Lilienfeld, ed.), Elsevier/North-Holland, Amsterdam, pp. 153–217.
Thomas, L., 1959, Discussion, in: Cellular and Humoral Aspects of Hypersensitive States, ( H. S. Lawrence, ed.), Cassell, London, p. 529.
Thompson, H. J., and Becci, P. J., 1980, Selenium inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat, J. Natl. Cancer Inst. 65: 1299–1301.
Thompson, H. J., Becci, P. J., Brown, C. C., and Moon, R. C., 1979, Effect of retinyl acetate feeding on inhibition of 1-methyl-1-nitrosourea-induced mammary carcinogenesis in the rat, Cancer Res. 39: 3977–3980.
Tonelli, Q. J., and Sorof, S., 1980, Epidermal growth factor requirement for development of cultured mammary glands, Nature 285: 250–252.
Tonelli, Q. J., and Sorof, S., 1981, Expression of a phenotype of normal differentiation in cultured mammary glands is promoted by epidermal growth factor and blocked by cyclic adenine nucleotide and prostaglandins, Differentiation 20: 253–259.
Topper, Y. J., and Oka, T., 1974, Some aspects of mammary gland development in mature mouse, in: Lactation: A Comprehensive Treatise, Volume 1, ( G. L. Larson and V. R. Smith, eds.), Academic Press, New York, pp. 327–348.
Vagenakis, A. G., Koutras, D. A., Burger, A., Malamos, B., Ingbar, S. H., and Braverman, L. E., 1973, Studies on serum triiodothyronine, thyroxine and thyrotropin concentrations in endemic goiter in Greece, J. Clin. Endocrinol. Metab. 37: 485–488.
Varmus, H., Bishop, J. M., Nowinski, R., and Sarkar, N., 1972, Mammary tumour virus specific nucleotide sequences in mouse DNA, Nature New Biol. 238: 189–191.
Wagner, D. A., Naylor, P. H., Kim, U., Shea, W., Ip, C., and Ip, M. M., 1982, Interaction of dietary fat and the thymus in the induction of mammary tumors by 7,12-dimethylbenz(a)anthracene, Cancer Res. 42: 1266–1273.
Wang, N., Yu, S. H., Leiner, I. E., Hebbel, R. P., Easton, J. W., and McKhann, C. F., 1982, Characterization of high-and low-metastatic clones derived from a methylcholanthreneinduced murine fibrosarcoma, Cancer Res. 42: 1046–1051.
Weinberg, R. A., 1981, Use of transfection to analyze genetic information and malignant transformation, Biochim. Biophys. Acta 651: 25–35.
Weinstein, I. B., 1981, Current concepts and controversies in chemical carcinogenesis, J. Su-promol. Struct. Cell. Biochem. 17: 99–120.
Weinstein, I. B., Gattoni-Celli, S., Kirschmeier, P., Hsiao, W., Horowitz, A., and Jeffrey, A., 1984, Cellular target and host genes in multistage carcinogenesis, Fed. Proc. 43: 2287–2294.
Welsch, C. W., and Meites, J., 1969, Effects of a norethynodrel—mestranol combination, (enovid), on development and growth of carcinogen-induced mammary tumors in female rats, Cancer 23: 601–607.
Welsch, C. W., and Nagasawa, H., 1977, Prolactin and murine mammary tumorigenesis: A review, Cancer Res. 37: 951–963.
Welsch, C. W., Nagasawa, H., and Meites, J., 1970, Increased incidence of spontaneous mammary tumors in female rats with induced hypothalamic lesions, Cancer Res. 30: 2310–2313.
Welsch, C. W., Bron, C. K., Goodrich-Smith, M., Chuisano, J., and Moon, R. C., 1980, Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of Nmethyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague—Dawley rats, Cancer Res. 40: 3095–3098.
Willmott, N., Austin, E. B., and Baldwin, R. W., 1979, Comparative studies of the metastasizing potential of three transplantable rat mammary carcinomas of spontaneous origin, Br. J. Exp. Pathol. 60: 499–506.
Wittliff, J. L., 1979, The steroid receptors of experimental mammary tumors, and their relationship to those of human-breast carcinoma, Mol. Aspects Med. 2: 395–437.
Wittliff, J. L., 1984, Steroid-hormone receptors in breast cancer, Cancer 53: 630–643.
Wolbach, S. D., and Howe, P. R., 1925, Tissue changes following deprivation of fat-soluble A vitamin, J. Exp. Med. 42: 753–777.
Wood, B. G., Washburn, L. L., Mukerjee, A. S., and Banerjee, M. R., 1975, Hormonal regulation of lobulo-alveolar growth, functional differentiation and regression of whole mouse mammary gland in organ culture, J. Endocrinol. 65: 1–6.
World Health Organization, 1981, Histological classification of tumours, No. 2, Histological typing of breast tumours, World Health Organization, 2nd ed., Geneva.
Wynder, E. L., Bross, I. J., and Hirayama, T., 1960, A study of the epidemiology of cancer of the breast, Cancer 13: 559–601.
Yanai, R., and Nagasawa, H., 1970, Effects of ergocornine and 2-Br-alpha-ergokryptin, (CB-154), on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice, Experientia 26: 645–650.
Yang, N. C., Castro, A. J., Lewis, M., and Wong, T. W., 1961, Polynuclear aromatic hydrocarbons, steroids and carcinogens, Science 134: 386–387.
Yogeeswaaran, G., and Salk, P., 1981, Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines, Science 212: 1514–1516.
Yokoro, K., and Furth, J., 1962, Determining role of “mammotropin” in induction of mammary tumors in mice by virus, J. Natl. Cancer Inst. 29: 887–909.
Yokoro, K., Furth, J., and Haran-Ghera, N., 1961, Induction of mammotropic pituitary tumors by X-rays in rats and mice: The role of mammotropes in development of mammary tumors, Cancer Res. 21: 178–186.
Yoo, T. J., Balint, J. P., Jr., Whiteaker, R. S., Floyd, R. A., and Kim, U., 1983, Circulating immune complexes in rats with metastasizing and nonmetastasizing mammary tumor, Int. Arch. Allergy Appl. Immunol. 71: 224–227.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Kim, U. (1985). Factors Influencing the Generation of Phenotypic Heterogeneity in Mammary Tumors. In: Mihich, E. (eds) Biological Responses in Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1236-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1236-9_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1238-3
Online ISBN: 978-1-4684-1236-9
eBook Packages: Springer Book Archive